Who
Randy Teel
President and CEO
Company insider
Files Form 4 as: President and CEO, Arvinas.
In numbers
- Trades disclosed
- 18
- Buys
- 0
- Sells
- 4
- Bought
- $0
- Sold
- $453K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 21 May 2024
- Last trade
- 21 May 2026
- Last filed
- 22 May 2026
Companies traded
Activity over time
1 Feb – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 May 2026filed 22 May 2026 | ARVN ArvinasBiotechnology | SEC FORM 4 Sold | $20K2,209 at $9.04 | filing |
| 21 May 2026filed 22 May 2026 | ARVN ArvinasBiotechnology | SEC FORM 4 Sold | $20K2,209 at $9.04 | filing |
| 11 May 2026filed 13 May 2026 | ARVN ArvinasBiotechnology | SEC FORM 4 Sold | $96K9,657 at $9.94 | filing |
| 11 May 2026filed 13 May 2026 | ARVN ArvinasBiotechnology | SEC FORM 4 Sold | $96K9,657 at $9.94 | filing |
| 26 Feb 2026filed 12 Mar 2026 | ARVN ArvinasBiotechnology | SEC FORM 4 Code A | —147,179 at $0.00 | filing |
| 26 Feb 2026filed 12 Mar 2026 | ARVN ArvinasBiotechnology | SEC FORM 4 Code A | —147,179 at $0.00 | filing |
| 26 Feb 2026filed 2 Mar 2026 | ARVN ArvinasBiotechnology | SEC FORM 4 Code A | —147,791 at $0.00 | filing |
| 26 Feb 2026filed 2 Mar 2026 | ARVN Arvinasoption or derivative · Biotechnology | SEC FORM 4 Code A | —218,691 at $0.00 | filing |
| 26 Feb 2026filed 2 Mar 2026 | ARVN Arvinasoption or derivative · Biotechnology | SEC FORM 4 Code A | —218,691 at $0.00 | filing |
| 26 Feb 2026filed 2 Mar 2026 | ARVN ArvinasBiotechnology | SEC FORM 4 Code A | —147,791 at $0.00 | filing |
| 23 Feb 2026filed 25 Feb 2026 | ARVN ArvinasBiotechnology | SEC FORM 4 Sold | $13K1,038 at $12.16 | filing |
| 23 Feb 2026filed 25 Feb 2026 | ARVN ArvinasBiotechnology | SEC FORM 4 Sold | $46K3,748 at $12.16 | filing |
| 23 Feb 2026filed 25 Feb 2026 | ARVN ArvinasBiotechnology | SEC FORM 4 Sold | $13K1,038 at $12.16 | filing |
| 23 Feb 2026filed 25 Feb 2026 | ARVN ArvinasBiotechnology | SEC FORM 4 Sold | $46K3,748 at $12.16 | filing |
| 13 Feb 2026filed 18 Feb 2026 | ARVN ArvinasBiotechnology | SEC FORM 4 Sold | $52K4,403 at $11.89 | filing |
| 13 Feb 2026filed 18 Feb 2026 | ARVN ArvinasBiotechnology | SEC FORM 4 Sold | $52K4,403 at $11.89 | filing |
| 21 May 2024filed 23 May 2024 | ARVN Arvinasoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,675 at $0.00 | filing |
| 21 May 2024filed 23 May 2024 | ARVN ArvinasBiotechnology | SEC FORM 4 Code A | —13,300 at $0.00 | filing |
News
Financial Comparison: Arvinas (NASDAQ:ARVN) & Geron (NASDAQ:GERN)ARVN · tickerreport.com · 20 Oct 2026
0 headlines in the last 90 days name Randy Teel; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.